 Connection
John Kincaid to Disease Progression
This is a "connection" page, showing publications John Kincaid has written about Disease Progression.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.469 |
|
|
|
-
Benson MD, Teague SD, Kovacs R, Feigenbaum H, Jung J, Kincaid JC. Rate of progression of transthyretin amyloidosis. Am J Cardiol. 2011 Jul 15; 108(2):285-9.
Score: 0.311
-
Dyck PJB, Coelho T, Waddington Cruz M, Brannagan TH, Khella S, Karam C, Berk JL, Polydefkis MJ, Kincaid JC, Wiesman JF, Litchy WJ, Mauermann ML, Ackermann EJ, Baker BF, Jung SW, Guthrie S, Pollock M, Dyck PJ. Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis. Muscle Nerve. 2020 10; 62(4):509-515.
Score: 0.148
-
Yazaki M, Yamashita T, Kincaid JC, Scott JR, Auger RG, Dyck PJ, Benson MD. Rapidly progressive amyloid polyneuropathy associated with a novel variant transthyretin serine 25. Muscle Nerve. 2002 Feb; 25(2):244-50.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|